Repligen's Q2 results top estimates

Repligen (RGEN) Q2: EPS of $0.14 beats by $0.04.

Revenue of $17.5M (+13% Y/Y) beats by $1.5M. (PR)

From other sites
Comments (2)
  • Stock Market Mike
    , contributor
    Comments (3734) | Send Message
    Most companies have been reporting losses or in-line results. RGEN's stock price always responds slowly to earnings news, but there should be more upside ahead. I hope my call options treat me well!
    1 Aug 2013, 12:14 PM Reply Like
  • francis williams
    , contributor
    Comments (25) | Send Message
    I stumbled into this one and will hold till I see or read some reliable
    info to the contrary. f
    1 Aug 2013, 04:05 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs